COMMUNIQUÉS West-GlobeNewswire

Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights

03/04/2018 - 23:15

- Recent initiation of STAR phase 3 trial in Choroideremia - - Begins 2018 with a cash position over $129 million - LEXINGTON, Mass. and LONDON, April 03, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ: [...]

New Patient-Centered Program Launched for New York Primary Care Practices

03/04/2018 - 23:14

NYS Patient-Centered Medical Home (NYS PCMH) Program Advances Primary Care, Addresses State’s Goals WASHINGTON, DC, April 03, 2018 (GLOBE NEWSWIRE) -- The National Committee for Quality Assurance (NCQA), creator of the [...]

Unum Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with Seattle Genetics

03/04/2018 - 23:00

CAMBRIDGE, Mass., April 03, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (“Unum Therapeutics”) (NASDAQ: UMRX ), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products [...]

Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge

03/04/2018 - 22:46

Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge First ever multiplex MDx test to be granted clearance by the FDA for this indication Commercial [...]

EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes

03/04/2018 - 22:36

Clinical Results Presented at the Southeastern Section of the American Urological Association Confirms HIFU's Safety, Efficacy and Benefits for Patients' Quality Of Life LYON, FRANCE, AUSTIN, TX -- APRIL 3, 2018 - EDAP [...]

BeyondSpring Files Its 2017 Annual Report on Form 20-F

03/04/2018 - 22:30

NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focusing on the development of innovative cancer therapies, today announced that the [...]

Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

03/04/2018 - 22:30

BERKELEY, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that on March 29, 2018 the Compensation Committee of Dynavax’s Board of Directors approved the grant [...]

The Cooper Companies Acquires The LifeGlobal Group, Expanding Fertility Solutions Portfolio

03/04/2018 - 22:15

PLEASANTON, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that CooperSurgical has acquired the assets of The LifeGlobal Group and its affiliates, a leading global [...]

The Ensign Group Acquires Arizona Skilled Nursing Facility

03/04/2018 - 22:15

MISSION VIEJO, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

03/04/2018 - 22:05

WAYNE, Pa., April 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference

03/04/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in Monte [...]

GBT Announces New Employment Inducement Grants

03/04/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that on April 2, 2018, the compensation committee of the Company’s board of directors [...]

Zosano Announces Closing of Public Offering of Common Stock

03/04/2018 - 22:05

FREMONT, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq: ZSAN ), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients [...]

Philadelphia Media Network Ranks Tabula Rasa HealthCare No. 6 on 2018 Top Places to Work

03/04/2018 - 21:29

Fast Growing Medication Risk Management Company’s Team Likes “Doing Good” MOORESTOWN, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC ) has been awarded a sixth place [...]

N.M. Medical Cannabis Program Soars Past 50,000 Milestone

03/04/2018 - 20:49

Enrollment increases 46 percent over last year, City of Albuquerque to decriminalize cannabis ALBUQUERQUE, N.M., April 03, 2018 (GLOBE NEWSWIRE) -- For the first time, New Mexico’s Medical Cannabis Program exceeded 50, [...]

I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina

03/04/2018 - 20:30

MONTREAL, April 03, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving regulatory approval from INVIMA in Colombia and ANMAT [...]

Announcement from Xbrane Biopharma's extra general meeting

03/04/2018 - 20:01

Press release 2018-04-03 The extra general meeting (" EGM ") of Xbrane Biopharma AB (" Xbrane Biopharma " or the " Company ") was held today on 3 April 2018 and the following resolutions were passed by the meeting. [...]

Rezolute, Inc. Announces Close of Convertible Note Financing

03/04/2018 - 19:26

LOUISVILLE, Colo., April 03, 2018 (GLOBE NEWSWIRE) -- Rezolute , Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT) , a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies [...]

Capital Increase in Genmab as a Result of Employee Warrant Exercise

03/04/2018 - 18:28

Company Announcement Copenhagen, Denmark; April 3, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 30,149 shares as a consequence of the exercise of employee warrants. The increase is [...]